114 related articles for article (PubMed ID: 3488573)
1. Cancer detection by immunoscintigraphy, selection, and clinical application of monoclonal anti-CEA antibodies and their F(ab')2 or Fab fragments.
Grob JP; Mach JP; Buchegger F; Schreyer M; Mosimann F; Besson A; Pettavel J; von Fliedner V; Bischof-Delaloye A; Delaloye B
Recent Results Cancer Res; 1986; 100():73-9. PubMed ID: 3488573
[No Abstract] [Full Text] [Related]
2. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.
Buchegger F; Haskell CM; Schreyer M; Scazziga BR; Randin S; Carrel S; Mach JP
J Exp Med; 1983 Aug; 158(2):413-27. PubMed ID: 6886623
[TBL] [Abstract][Full Text] [Related]
4. F(ab')2 fragments versus intact antibody--an isodose comparison.
Humm JL; Chin LM; Macklis RM
J Nucl Med; 1990 Jun; 31(6):1045-7. PubMed ID: 2189961
[No Abstract] [Full Text] [Related]
5. Radiolocalisation of an anti-CEA monoclonal antibody (FO23C5) and its fragments in a colon carcinoma xenograft model.
Rowlinson G; Paganelli G; Snook D; Epenetos AA
Int J Biol Markers; 1988; 3(4):259-64. PubMed ID: 3235854
[TBL] [Abstract][Full Text] [Related]
6. Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice.
Buchegger F; Pèlegrin A; Delaloye B; Bischof-Delaloye A; Mach JP
J Nucl Med; 1990 Jun; 31(6):1035-44. PubMed ID: 2348233
[TBL] [Abstract][Full Text] [Related]
7. Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.
Sutherland R; Buchegger F; Schreyer M; Vacca A; Mach JP
Cancer Res; 1987 Mar; 47(6):1627-33. PubMed ID: 3545451
[TBL] [Abstract][Full Text] [Related]
8. Immunoscintigraphy of colon carcinoma.
Chatal JF; Saccavini JC; Fumoleau P; Douillard JY; Curtet C; Kremer M; Le Mevel B; Koprowski H
J Nucl Med; 1984 Mar; 25(3):307-14. PubMed ID: 6366160
[TBL] [Abstract][Full Text] [Related]
9. Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.
Vogel CA; Bischof-Delaloye A; Mach JP; Pèlegrin A; Hardman N; Delaloye B; Buchegger F
Br J Cancer; 1993 Oct; 68(4):684-90. PubMed ID: 8398694
[TBL] [Abstract][Full Text] [Related]
10. [Immunoscintigraphy using radio-labeled monoclonal antibodies. Development of a method of cancer diagnosis and hopes for a new form of therapy].
Mach JP; Bischof-Delaloye A; Curchod S; Studer A; Grob JP; Volant JC; Mosimann F; Givel JC; Douglas P; Leyvraz S
Schweiz Med Wochenschr; 1987 Jul; 117(29):1076-86. PubMed ID: 3499666
[TBL] [Abstract][Full Text] [Related]
11. Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.
Pedley RB; Boden JA; Boden R; Dale R; Begent RH
Br J Cancer; 1993 Jul; 68(1):69-73. PubMed ID: 8318423
[TBL] [Abstract][Full Text] [Related]
12. Higher efficiency of 131I-labeled anti-carcinoembryonic antigen-monoclonal antibody F(ab')2 as compared to intact antibodies in radioimmunotherapy of established human colon carcinoma grafted in nude mice.
Buchegger F; Mach JP; Folli S; Delaloye B; Bischof-Delaloye A; Pèlegrin A
Recent Results Cancer Res; 1996; 141():19-35. PubMed ID: 8722418
[No Abstract] [Full Text] [Related]
13. Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy.
Behr TM; Memtsoudis S; Sharkey RM; Blumenthal RD; Dunn RM; Gratz S; Wieland E; Nebendahl K; Schmidberger H; Goldenberg DM; Becker W
Int J Cancer; 1998 Aug; 77(5):787-95. PubMed ID: 9688314
[TBL] [Abstract][Full Text] [Related]
14. Immunoscintigraphy of gastric or colon carcinoma with F(ab')2 fragments of anti-CEA monoclonal antibody.
Amendolagine F; Allegra V; Tenti M; Lobrano V; Pannozzo G
Rays; 1987; 12(1):67-71. PubMed ID: 3628863
[No Abstract] [Full Text] [Related]
15. Comparison of therapeutic efficacy and host toxicity of two different 131I-labelled antibodies and their fragments in the GW-39 colonic cancer xenograft model.
Blumenthal RD; Sharkey RM; Kashi R; Goldenberg DM
Int J Cancer; 1989 Aug; 44(2):292-300. PubMed ID: 2759735
[TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody.
Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R
Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunotherapy of human colon carcinoma by 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model.
Buchegger F; Vacca A; Carrel S; Schreyer M; Mach JP
Int J Cancer; 1988 Jan; 41(1):127-34. PubMed ID: 3335416
[TBL] [Abstract][Full Text] [Related]
18. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
Buchegger F; Pfister C; Fournier K; Prevel F; Schreyer M; Carrel S; Mach JP
J Clin Invest; 1989 May; 83(5):1449-56. PubMed ID: 2708519
[TBL] [Abstract][Full Text] [Related]
19. Significance of circulatory clearance of tumour-localising IgG and F(ab')2 for potential therapy studied in a CEA-producing xenograft model.
Harwood PJ; Pedley RB; Boden J; Rogers GT
Tumour Biol; 1987; 8(1):19-25. PubMed ID: 3602844
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapy of athymic mice bearing GW-39 human colonic cancer micrometastases with 131I-labeled monoclonal antibodies.
Blumenthal RD; Sharkey RM; Haywood L; Natale AM; Wong GY; Siegel JA; Kennel SJ; Goldenberg DM
Cancer Res; 1992 Nov; 52(21):6036-44. PubMed ID: 1394228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
